Question # 1 (Multiple Answer) Chloroquine (Aralen) pharmacology:

A) effective against gametocytes of P falciparum
B) used to treat P vivax, P ovale, P. malariae attacks
C) both
D) neither

Question # 2 (Multiple Choice) chloroquine (Aralen) contraindications:

A) patients with retinal/visual field abnormalities
B) in patients predisposed to porphyria
C) both
D) neither

Question # 3 (Multiple Answer) Clinical uses: chloroquine (Aralen)-

A) amebiasis
B) malaria prophylaxis
C) acute malarial attacks
D) autoimmune disease

Question # 4 (Multiple Answer) Mefloquine (Lariam) antimalarial properties:

A) active against P falciparum gametocytes
B) blood schizonticidal activity against P falciparum & P vivax
C) inactive against hepatic stages of P vivax

Question # 5 (Multiple Answer) Contraindication(s): mefloquine (Lariam)-

A) epilepsy
B) cardiac conduction anomalies
C) psychiatric disturbance

Question # 6 (Multiple Answer) Antimalarial property/properties: primaquine --

A) active against late hepatic stages
B) active against primary exoerythrocytic P falciparum stage
C) prophylaxis with chloroquine (Aralen) against P ovale
D) highly gametocidal against P vivax

Question # 7 (Multiple Choice) Clinical uses: primaquine

A) treatment of Pneumocystis carinii pneumonia
B) radical cure of acute P ovale malaria
C) both
D) neither

Question # 8 (Multiple Choice) Clinical uses: chloroguanide

A) malarial chemoprophylaxis
B) Toxoplasmosis
C) both
D) neither

Question # 9 (Multiple Answer) Characteristics of quinine (Quinamm) antimalarial activity:

A) slow onset
B) poorly effective blood schizonticide against P vivax
C) gametocidal for P ovale

Question # 10 (Multiple Answer) Adverse effects-quinine (Quinamm):

A) epigastric pain
B) cinchonism
C) hypoglycemia
D) paresthesias
E) temporal arteritis